Kyle Mikson
Stock Analyst at Canaccord Genuity
(0.91)
# 3,687
Out of 4,847 analysts
88
Total ratings
24.32%
Success rate
-16.93%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AKYA Akoya Biosciences | Maintains: Hold | $1.8 → $1.08 | $1.14 | -5.26% | 5 | May 19, 2025 | |
| GRAL GRAIL | Maintains: Buy | $32 → $43 | $38.55 | +11.54% | 2 | May 14, 2025 | |
| BDSX Biodesix | Maintains: Buy | $2.5 → $1.5 | $0.30 | +399.00% | 4 | May 14, 2025 | |
| XGN Exagen | Maintains: Buy | $7 → $8 | $7.30 | +9.59% | 3 | May 13, 2025 | |
| QTRX Quanterix | Maintains: Buy | $15 → $12 | $5.41 | +121.81% | 6 | May 13, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $18 → $15 | $9.11 | +64.65% | 8 | May 12, 2025 | |
| ILMN Illumina | Maintains: Hold | $92 → $87 | $81.83 | +6.32% | 10 | May 12, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $42 → $37 | $16.71 | +121.42% | 4 | May 6, 2025 | |
| GH Guardant Health | Maintains: Buy | $60 → $65 | $45.79 | +41.95% | 7 | May 1, 2025 | |
| RGEN Repligen | Maintains: Hold | $170 → $150 | $124.61 | +20.38% | 3 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.05 | +185.71% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $195 | $160.15 | +21.76% | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.26 | +138.10% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1.5 → $1 | $1.76 | -43.18% | 3 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $75 | $54.84 | +36.76% | 9 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.54 | +271.13% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.60 | +8,106.84% | 1 | Mar 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $19 | $3.91 | +386.56% | 1 | Jan 29, 2021 |
Akoya Biosciences
May 19, 2025
Maintains: Hold
Price Target: $1.8 → $1.08
Current: $1.14
Upside: -5.26%
GRAIL
May 14, 2025
Maintains: Buy
Price Target: $32 → $43
Current: $38.55
Upside: +11.54%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $2.5 → $1.5
Current: $0.30
Upside: +399.00%
Exagen
May 13, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $7.30
Upside: +9.59%
Quanterix
May 13, 2025
Maintains: Buy
Price Target: $15 → $12
Current: $5.41
Upside: +121.81%
10x Genomics
May 12, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $9.11
Upside: +64.65%
Illumina
May 12, 2025
Maintains: Hold
Price Target: $92 → $87
Current: $81.83
Upside: +6.32%
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $42 → $37
Current: $16.71
Upside: +121.42%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $60 → $65
Current: $45.79
Upside: +41.95%
Repligen
Apr 16, 2025
Maintains: Hold
Price Target: $170 → $150
Current: $124.61
Upside: +20.38%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.05
Upside: +185.71%
Feb 28, 2025
Maintains: Buy
Price Target: $180 → $195
Current: $160.15
Upside: +21.76%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.26
Upside: +138.10%
Nov 13, 2024
Maintains: Hold
Price Target: $1.5 → $1
Current: $1.76
Upside: -43.18%
Nov 6, 2024
Maintains: Buy
Price Target: $95 → $75
Current: $54.84
Upside: +36.76%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.54
Upside: +271.13%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.60
Upside: +8,106.84%
Jan 29, 2021
Initiates: Overweight
Price Target: $19
Current: $3.91
Upside: +386.56%